{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:44:40Z","timestamp":1774669480845,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["tipsro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Technical Innovations &amp; Patient Support in Radiation Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.tipsro.2024.100237","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:46:23Z","timestamp":1705553183000},"page":"100237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy"],"prefix":"10.1016","volume":"29","author":[{"given":"Paulo","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u00e7a","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelina","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0059-4913","authenticated-orcid":false,"given":"Michael","family":"Kos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tipsro.2024.100237_b0005","doi-asserted-by":"crossref","unstructured":"Rawla Prashanth s.l. Epidemiology of prostate cancer. World J Oncol 2019; 10(2): 63\u201389.","DOI":"10.14740\/wjon1191"},{"key":"10.1016\/j.tipsro.2024.100237_b0010","doi-asserted-by":"crossref","unstructured":"Bolla M, Henry A, Mason M, Wiegeld Tsl. The role of radiotherapy in localised and locally advanced prostate cancer. Asian J Urol 2019;6(2): 153\u2013161.","DOI":"10.1016\/j.ajur.2019.02.001"},{"key":"10.1016\/j.tipsro.2024.100237_b0015","doi-asserted-by":"crossref","unstructured":"Markovina S, Meeks M, Badiyan S, Vetter B, Gay H, Paradis A, et al. Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: a propensity score-matched analysis Adv Radiat Oncol 2018;3(2): 190\u20136.","DOI":"10.1016\/j.adro.2017.12.001"},{"key":"10.1016\/j.tipsro.2024.100237_b0020","doi-asserted-by":"crossref","unstructured":"Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. s.l. The Lancet Oncol 2007; 2007;8(6):475\u2013487.","DOI":"10.1016\/S1470-2045(07)70143-2"},{"key":"10.1016\/j.tipsro.2024.100237_b0025","doi-asserted-by":"crossref","unstructured":"Glass AS, Cowan JE, Fuldeore MJ, et al. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era. s.l.: Urology 2013;82(1):60\u20135.","DOI":"10.1016\/j.urology.2013.01.072"},{"issue":"3","key":"10.1016\/j.tipsro.2024.100237_b0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2008.04.063","article-title":"Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer","volume":"73","author":"Al-Mamgani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2024.100237_b0035","doi-asserted-by":"crossref","unstructured":"Vanneste BGL, Van De Voorde L, de Ridder RJ, Van Limbergen EJ, Lambin P, van Lin EN. Chronic radiation proctitis: tricks to prevent and treat s.l.: Int J Colorectal Disease 2015;30(10):1293\u20131303.","DOI":"10.1007\/s00384-015-2289-4"},{"key":"10.1016\/j.tipsro.2024.100237_b0040","doi-asserted-by":"crossref","unstructured":"Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI. 1124-9. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. s.l.: Int J Radiat Oncol Biol Phys 2008;70(4).","DOI":"10.1016\/j.ijrobp.2007.11.044"},{"key":"10.1016\/j.tipsro.2024.100237_b0045","doi-asserted-by":"crossref","unstructured":"Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. s.l.: Int J Radiat Oncol Biol Phys 2002;Dec;54(5):1314\u201321.","DOI":"10.1016\/S0360-3016(02)03742-2"},{"key":"10.1016\/j.tipsro.2024.100237_b0050","doi-asserted-by":"crossref","unstructured":"Vargas C, Martinez A, Kestin LL. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer. s.l.: Int J Radiat Oncol Biol Phys 2005; 62: 1297\u2013308.","DOI":"10.1016\/j.ijrobp.2004.12.052"},{"key":"10.1016\/j.tipsro.2024.100237_b0055","doi-asserted-by":"crossref","unstructured":"Noyes WR, Hosford CC, Schultz SE. Human collagen injections to reduce rectal dose during radiotherapy. s.l.: Int J Radiat Oncol Biol Phys 2012;Vol. Apr 1;82(5)1918\u201322.","DOI":"10.1016\/j.ijrobp.2011.02.034"},{"key":"10.1016\/j.tipsro.2024.100237_b0060","doi-asserted-by":"crossref","unstructured":"Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. s.l.: Int J Radiat Oncol Biol Phys 2015;92 (5): 971\u20137.","DOI":"10.1016\/j.ijrobp.2015.04.030"},{"key":"10.1016\/j.tipsro.2024.100237_b0065","doi-asserted-by":"crossref","unstructured":"Mariados NF, Orio PF III, Schiffman Z, Van TT, Engelman A, Nurani R, Kurtzman SM et al. Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial s.l.: JAMA Oncol 2023; Vol. 9: e227592.","DOI":"10.1001\/jamaoncol.2022.7592"},{"key":"10.1016\/j.tipsro.2024.100237_b0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jmir.2022.09.008","article-title":"Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experience","volume":"Vols. Dec; 53(4)","author":"Williams","year":"2022","journal-title":"J Med Imaging Radiat Sci"},{"key":"10.1016\/j.tipsro.2024.100237_b0075","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.urology.2021.05.013","article-title":"SpaceOAR hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. a systematic review","volume":"Vols. Oct; 156","author":"Armstrong","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.tipsro.2024.100237_b0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1748-717X-8-96","article-title":"Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study","volume":"Vol. 8","author":"Gez","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.tipsro.2024.100237_b0085","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). s.l.: Available at: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"key":"10.1016\/j.tipsro.2024.100237_b0090","doi-asserted-by":"crossref","unstructured":"Vanneste BGL, van De Beek K, Lutgens L, Lambin P. Implantation of a biodegradable rectum balloon implant: tips, Tricks and pitfalls. s.l.: s. Int Braz J Urol 2017; Vol. 43 (6): 1033\u201342.","DOI":"10.1590\/s1677-5538.ibju.2016.0494"},{"key":"10.1016\/j.tipsro.2024.100237_b0095","doi-asserted-by":"crossref","unstructured":"Salembier C, Villeirs G, De Bari B, Hoskin P, Pieters BR, Van Vulpen M, et al. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer. s.l.: Radiother Oncol 2018; Vol. 127(1): 49-61.","DOI":"10.1016\/j.radonc.2018.01.014"},{"key":"10.1016\/j.tipsro.2024.100237_b0100","doi-asserted-by":"crossref","unstructured":"Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. s.l.: Int J Radiat Oncol Biol Phys Vol. Jan 1;28(1):33-7.","DOI":"10.1016\/0360-3016(94)90138-4"},{"issue":"3","key":"10.1016\/j.tipsro.2024.100237_b0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jrr\/rraa013","article-title":"Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy","volume":"1","author":"Saito","year":"2020","journal-title":"J Radiat Res"},{"key":"10.1016\/j.tipsro.2024.100237_b0110","doi-asserted-by":"crossref","unstructured":"Latorzeff I, Brugui\u00e8re E, Bogart E, Le Deley M-C, Lartigau E, Marre D, Pasquier D. Use of a bidegradable, contrast-filled rectal spacer balloon in intensity-modulated radiotherapy for intermediate-risk prostate cancer patients: Dosimetric gains in the BioPro-RCMI-1505 study. s.l.: Front Oncol 2021.","DOI":"10.3389\/fonc.2021.701998"},{"key":"10.1016\/j.tipsro.2024.100237_b0115","article-title":"Multicenter, dual fractionation scheme, single core lab comparison of rectal volume dose reduction following injection of two biodegradable perirectal spacers","volume":"Vol. 24(10):e14086","author":"Kos","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.tipsro.2024.100237_b0120","doi-asserted-by":"crossref","unstructured":"Vanneste BGL, van Wijk Y, Lutgens LC, et al. Dynamics of rectal balloon implant shrinkage in prostate VMAT : Influence on anorectal dose and late rectal complication risk. Dynamiken eines schrumpfenden rektalen Ballonimplantats w\u00e4hrend Prostata-VMAT : Einfluss auf anorektale Dosis und das Risiko f\u00fcr. s.l.: Strahlenther Onkol 2018; Vol. 194(1): 31-40.","DOI":"10.1007\/s00066-017-1222-x"},{"key":"10.1016\/j.tipsro.2024.100237_b0125","doi-asserted-by":"crossref","unstructured":"Wolf F, Gaisberger C, Ziegler I, et al. Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency. Comparison. s.l.: Radiother Oncol 2015; Vols. 116(2):221\u20135.","DOI":"10.1016\/j.radonc.2015.07.027"},{"key":"10.1016\/j.tipsro.2024.100237_b0130","doi-asserted-by":"crossref","unstructured":"Ben-Yosef R, Paz A, Levy Y, Alani S, Muncher Y, Shohat S, et al. A novel device for protecting rectum during prostate cancer irradiation: in vivo data on a large mammal model. s.l.: J Urol., 2009; Vol. 181(3): 1401-6.","DOI":"10.1016\/j.juro.2008.11.010"},{"key":"10.1016\/j.tipsro.2024.100237_b0135","doi-asserted-by":"crossref","unstructured":"Sch\u00f6rghofer A, Drerup M, Kunit T, Lusuardi L, Holzinger J, Karne J. Rectum-spacer related acute toxicity \u2013 endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers. s.l.: Radiation Onco, 2019, Vol. 14: 47 .","DOI":"10.1186\/s13014-019-1248-6"},{"key":"10.1016\/j.tipsro.2024.100237_b0140","doi-asserted-by":"crossref","unstructured":"Shelley LEA, Scaife JE, Romanchikova M, Harrison K, Forman JR, Bates AM, et al. Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy. s.l.: Radiother Oncol 2017; Vol. Jun;123(3): 466-471.","DOI":"10.1016\/j.radonc.2017.04.008"},{"key":"10.1016\/j.tipsro.2024.100237_b0145","doi-asserted-by":"crossref","unstructured":"Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, et al. Continued benefit to rectal separation for prostate radiation therapy: Final results of a Phase III trial. s.l.: Int J Radiat Oncol Biol Phys 2017; Vol. 97 (5): 976-85.","DOI":"10.1016\/j.ijrobp.2016.12.024"},{"key":"10.1016\/j.tipsro.2024.100237_b0150","doi-asserted-by":"crossref","unstructured":"Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. . Zelefsky MJ, Crean D, Mageras GS, Lyass O, Happersett L, Ling CC, et al. s.l.: Radiother Oncol., 1999, Vols. 50(2):225\u201334.","DOI":"10.1016\/S0167-8140(99)00011-0"},{"key":"10.1016\/j.tipsro.2024.100237_b0155","doi-asserted-by":"crossref","unstructured":"Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder. Pinkawa M, Asadpour B, Gagel B, Piroth MD, Holy R, Eble MJ. s.l.: Int J Radiat Oncol Biol Phys. , 2006, Vols. 64(3):856\u201361.","DOI":"10.1016\/j.ijrobp.2005.08.016"}],"container-title":["Technical Innovations &amp; Patient Support in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632424000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632424000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:17:18Z","timestamp":1762503438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405632424000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"alternative-id":["S2405632424000040"],"URL":"https:\/\/doi.org\/10.1016\/j.tipsro.2024.100237","relation":{},"ISSN":["2405-6324"],"issn-type":[{"value":"2405-6324","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Technical Innovations & Patient Support in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tipsro.2024.100237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100237"}}